BioSpace News Archive

Pharm Country

Siblings with autism share more of dad’s genome, not mom’s

Scientists long thought that siblings born with ASD share more of their mother’s genome than their father’s.

May 22, 2023
·
2 min read
Business

Potrero Medical welcomes The Honorable David Shulkin, M.D. Former U.S. Secretary of Veterans Affairs, to their Advisory Board

Potrero Medical announced today that Secretary Shulkin has joined its advisory board, he is a healthcare leader and policy expert with over 20 years of experience in both private and government sectors.

May 22, 2023
·
2 min read
Revolo Biotherapeutics Presents New Preclinical Data for ‘1104 in Acute Respiratory Distress Syndrome Associated With Influenza Infection at the ATS 2023 International Conference

Revolo Biotherapeutics (“Revolo” or the “Company”), a company developing therapies that reset the immune system to achieve superior long-term remission for patients with autoimmune and allergic diseases, today announced new preclinical data discussed in a poster presentation at the American Thoracic Society (ATS) 2023 International Conference.

May 22, 2023
·
3 min read
BioForest

Outpace Bio Expands Seattle Presence with Cell Therapy Research Hub & Collaborations with Leading Experts in Protein Design & Cancer Immunotherapy

Outpace Bio, a company using protein design and cell engineering to create advanced cell therapies with curative potential, announced the expansion of its research facilities and new collaborations with leading scientists at Fred Hutchinson Cancer Center and the Institute for Protein Design at the University of Washington School of Medicine.

May 22, 2023
·
3 min read
Genetown

Rhythm Pharmaceuticals and Genpharm Announce Collaboration to Provide IMCIVREE® (setmelanotide) to Patients in Gulf Cooperation Council Countries

Rhythm Pharmaceuticals, Inc. announced a collaboration with Genpharm Services FZ LLC to commercialize IMCIVREE® in Gulf Cooperation Council countries, including Saudi Arabia, United Arab Emirates, Kuwait, Qatar, Oman and Bahrain.

May 22, 2023
·
10 min read
Biotech Beach

Poseida Therapeutics to Present at 31st Congress of the International Society on Thrombosis and Haemostasis

Poseida Therapeutics, Inc. today announced that two abstracts have been accepted for presentation at the 31st Congress of the International Society on Thrombosis and Haemostasis (ISTH), being held in Montreal, Canada and virtually on June 24-28, 2023.

May 22, 2023
·
4 min read
Drug Development

Hepion Pharmaceuticals’ Phase 2 ‘ALTITUDE-NASH’ Trial Achieves Primary and Secondary Endpoints, Including Improvement in Liver Function and Multiple NASH Biomarkers

Hepion Pharmaceuticals, Inc. today announced positive topline results from its recently completed Phase 2 ALTITUDE-NASH clinical trial.

May 22, 2023
·
14 min read
Deals

Krystal Biotech Announces $160 Million Private Placement Equity Financing

Krystal Biotech, Inc. today announced that it has entered into a securities purchase agreement for the sale of 1,729,729 shares of its common stock at $92.50 per share in a private placement (the PIPE) to certain qualified institutional buyers.

May 22, 2023
·
4 min read
Pharm Country

Seelos Therapeutics to Participate in Two Upcoming Healthcare Conferences

Seelos Therapeutics, Inc. today announced that it will participate in two upcoming healthcare conferences.

May 22, 2023
·
2 min read
Business

Kelyniam Global Releases Q1 Financials, Announces Licensing Agreement with Bioplate for Osteopore Products

Kelyniam Global, a leading maker of custom cranial implants, announced results for its quarter ended March 31, 2023.

May 22, 2023
·
3 min read